e-Drug3D

2147

BENZGALANTAMINE


INN
BENZGALANTAMINE

(has an active metabolite)

cas 224169-27-1
CLASS

NERVOUS SYSTEM
CHOLINESTERASE INHIBITOR
TREATMENT OF MILD TO MODERATE DEMENTIA OF THE ALZHEIMER

ROUTE (list)

ORAL

ATC code

N06DA04

PK parameters

Solubility

SOLUBLE IN WATER


Target

TARGET CHOLINESTERASE

DrugCentral

-

Download SDF file 6H-Benzofuro[3a,3,2-ef][2]benzazepin-6-ol, 4a,5,9,10,11,12-hexahydro-3-methoxy-11-methyl-, 6-benzoate, (4aS,6R,8aS)- (ACI)

Formula:
C24H25NO4

Calculated chemical properties:

MW 391.45
NB_atoms 29
XLogP 3.72
PSA 51.129
NB_HD 0
NB_HA 5
fsp3 0.38
Lipinski(0=no;1=yes) 1

FDA
NDA 218549 (pdf not found) INN (BENZGALANTAMINE GLUCONATE) ZUNVEYL (ALPHA COGNITION) APPROVAL= AP YEAR= 2024

Other links:

PubChem
ChemicalProbes

U.S. repository of Clinical Trials

VigiAccess
SIDER side effects

ChemSynthesis
Patent@SureChEMBL